Document Detail


Effects of propranolol on coronary vasculature and cardiac performance in dogs with fixed and dynamic coronary stenosis.
MedLine Citation:
PMID:  2632837     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The coronary hemodynamic effects of propranolol (0.1 mg/kg, i.v.) were examined in anesthetized dogs with flow-limiting dynamic and fixed coronary stenosis of the left circumflex coronary artery. During fixed coronary stenosis created by external application of an occluder device, propranolol significantly decreased coronary blood flow (CBF) by 6.8 +/- 2.7% (mean +/- SEM, p less than 0.05) and increased mean distal coronary pressure (DCP) by 7 +/- 2.1 mmHg (p less than 0.05). This resulted in a decrease in stenosis resistance (SR) by 26 +/- 3.1% (p less than 0.01) due to oxygen demand reduction. By contrast, during dynamic coronary stenosis produced by an intraluminal microballoon occluder, propranolol decreased CBF by 68 +/- 3.4% (p less than 0.01) and mean DCP by 36 +/- 4.2 mmHg (p less than 0.01), resulting in an increase in SR by 694 +/- 109% (p less than 0.01). This increase in SR was attenuated by pretreatment with an alpha-adrenergic receptor antagonist phentolamine (0.5 mg/kg, i.v.), or by holding heart rate constant at the pretreatment level. These results suggest that propranolol ameliorated the severity of stenosis during fixed coronary stenosis and exacerbated the severity during dynamic coronary stenosis. This increase in SR appears to be related to vasoconstriction of the large stenosed coronary artery, mediated both by alpha-adrenergic receptors in the coronary artery and by myocardial oxygen demand reduction.
Authors:
M Kashiki; M Yokoyama; H Fukuzaki
Related Documents :
94407 - Increased diastolic time: a possible important factor in the benefical effect of propra...
7038157 - A randomized trial of propranolol in patients with acute myocardial infarction. i. mort...
1225337 - Investigation of the safe withdrawal period for propranolol in patients scheduled for o...
2968237 - Thyroxine-induced cardiac hypertrophy: time course of development and inhibition by pro...
2733537 - Laser recanalization of pyloric stenosis: a guidewire-directed contact probe technique.
8764527 - Prevalence of myocardial ischemia as depicted by regional wall motion abnormality in bl...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Japanese heart journal     Volume:  30     ISSN:  0021-4868     ISO Abbreviation:  Jpn Heart J     Publication Date:  1989 Nov 
Date Detail:
Created Date:  1990-05-11     Completed Date:  1990-05-11     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0401175     Medline TA:  Jpn Heart J     Country:  JAPAN    
Other Details:
Languages:  eng     Pagination:  853-61     Citation Subset:  IM    
Affiliation:
First Department of Medicine, Kobe University School of Medicine, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Constriction
Coronary Circulation / drug effects
Coronary Disease / drug therapy*
Coronary Vessels / drug effects*
Dogs
Hemodynamics / drug effects*
Propranolol / therapeutic use*
Chemical
Reg. No./Substance:
525-66-6/Propranolol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effect of sodium intake on the hypotensive effect of calcium antagonists.
Next Document:  Origin of the giant R wave in acute transmural myocardial infarction in the pig.